Search hospitals > California > San Francisco
California Pacific Medical Center
Claim this profileSan Francisco, California 94115
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Motor Neuron Disease
Conducts research for Amyotrophic Lateral Sclerosis
Conducts research for Hepatitis
Conducts research for Multiple Sclerosis
228 reported clinical trials
9 medical researchers
Summary
California Pacific Medical Center is a medical facility located in San Francisco, California. This center is recognized for care of Human Immunodeficiency Virus Infection, Motor Neuron Disease, Amyotrophic Lateral Sclerosis, Hepatitis, Multiple Sclerosis and other specialties. California Pacific Medical Center is involved with conducting 228 clinical trials across 224 conditions. There are 9 research doctors associated with this hospital, such as Ari Baron, MD, Christian Spies, MD, Jonathan Katz, MD, and Kidist Yimam, MD.Area of expertise
1Human Immunodeficiency Virus Infection
Global Leader2Motor Neuron Disease
Global LeaderSOD1 positive
Stage I
Stage II
Top PIs
Ari Baron, MDAlta Bates Summit Medical Center-Herrick Campus7 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
27 reported clinical trials
62 drugs studied
Christian Spies, MDCalifornia Pacific Medical Center5 years of reported clinical research
Studies Tricuspid Regurgitation
Studies Mitral Valve Regurgitation
4 reported clinical trials
7 drugs studied
Jonathan Katz, MDCalifornia Pacific Medical Center Research Institute2 years of reported clinical research
Studies Motor Neuron Disease
Studies Amyotrophic Lateral Sclerosis
4 reported clinical trials
7 drugs studied
Kidist Yimam, MDCalifornia Pacific Medical Center1 year of reported clinical research
Studies Primary Sclerosing Cholangitis
Studies Cholangitis
2 reported clinical trials
3 drugs studied
Clinical Trials running at California Pacific Medical Center
Non-Small Cell Lung Cancer
Subdural Hematoma
Cancer
Tricuspid Regurgitation
Pancreatic Cancer
Ischemic Stroke
Stroke
Endometrial Cancer
Amyotrophic Lateral Sclerosis
Autoimmune Hepatitis
AK112
for Non-Small Cell Lung Cancer
A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112 or Placebo Combined With Pemetrexed and Carboplatin in Patients With EGFR-mutant Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Who Have Progressed on or Following Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Treatment (HARMONi)
Recruiting1 award Phase 35 criteria
AK112
for Non-Small Cell Lung Cancer
A Randomized, Double-blind, Multi-center, Phase III Clinical Study of Ivonescimab (SMT112 or AK112) or Placebo Plus Pemetrexed and Carboplatin in Patients With EGFR-mutant Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Who Have Progressed on or Following Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Treatment (HARMONi)
Recruiting1 award Phase 310 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at California Pacific Medical Center?
California Pacific Medical Center is a medical facility located in San Francisco, California. This center is recognized for care of Human Immunodeficiency Virus Infection, Motor Neuron Disease, Amyotrophic Lateral Sclerosis, Hepatitis, Multiple Sclerosis and other specialties. California Pacific Medical Center is involved with conducting 228 clinical trials across 224 conditions. There are 9 research doctors associated with this hospital, such as Ari Baron, MD, Christian Spies, MD, Jonathan Katz, MD, and Kidist Yimam, MD.